fbpx Skip to main content

Member's Profile

Cirius Therapeutics

12651 High Bluff Drive, Suite 150
San Diego,   CA
United States
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Cirius Therapeutics
Biotech Company
Cirius Therapeutics, a clinical-stage pharmaceutical company, is developing MSDC-0602K, a novel metabolic treatment for nonalcoholic steatohepatitis (NASH). MSDC-0602K is currently being evaluated in a Phase 2b clinical trial. Through its novel mechanism of action that reduces insulin resistance and restores metabolic balance, MSDC-0602K has potential to resolve the underlying pathophysiology of NASH.
Related News
No related news posted by this Member